Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models

Background Thrombosis is a major disorder which is an outcome of an imbalance in the hemostatic system that develop undesirable blood clot and hinder blood circulation. Purpose The current study was designed to verify the potential of aqueous methanolic crude extract of Asphodelus tenuifolius Cav ....

Full description

Bibliographic Details
Main Authors: Humaira Gul, Ayesha Jamshed, Qaiser Jabeen
Format: Article
Language:English
Published: SAGE Publishing 2022-09-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/15593258221127566
_version_ 1797995186668699648
author Humaira Gul
Ayesha Jamshed
Qaiser Jabeen
author_facet Humaira Gul
Ayesha Jamshed
Qaiser Jabeen
author_sort Humaira Gul
collection DOAJ
description Background Thrombosis is a major disorder which is an outcome of an imbalance in the hemostatic system that develop undesirable blood clot and hinder blood circulation. Purpose The current study was designed to verify the potential of aqueous methanolic crude extract of Asphodelus tenuifolius Cav . (At.Cr), used traditionally as remedy in circulatory problems. Research Design Antioxidant activity, FTIR, and HPLC analysis were performed. In-vitro clot lysis assay was performed on human blood samples, and in-vivo acute pulmonary thromboembolism model was developed by administering the mixture of collagen and epinephrine in tail vein of mice. Carrageenan-induced thrombosis and FeCl 3 -induced carotid arterial thrombosis models were developed in rats. Results At.Cr demonstrated significant increase in lysis of human blood clot. Bleeding and clotting times were increased dose-dependently. Lungs histology showed clear alveolar spaces with decreased red blood cells congestion. Reduction in infarcted tail length, augmentation in prothrombin time, and activated partial thromboplastin time with decrease in platelet count were observed. At.Cr also prolonged the arterial occlusion time and reduced the weight of thrombus and TXB 2 levels dose-dependently. Conclusions The results demonstrated the antithrombotic and thrombolytic potential of At.Cr due to activation of coagulation factors through extrinsic and intrinsic pathways.
first_indexed 2024-04-11T09:57:25Z
format Article
id doaj.art-8e9ce262ecc641a0969dc5d01c4d017f
institution Directory Open Access Journal
issn 1559-3258
language English
last_indexed 2024-04-11T09:57:25Z
publishDate 2022-09-01
publisher SAGE Publishing
record_format Article
series Dose-Response
spelling doaj.art-8e9ce262ecc641a0969dc5d01c4d017f2022-12-22T04:30:31ZengSAGE PublishingDose-Response1559-32582022-09-012010.1177/15593258221127566Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental ModelsHumaira GulAyesha JamshedQaiser JabeenBackground Thrombosis is a major disorder which is an outcome of an imbalance in the hemostatic system that develop undesirable blood clot and hinder blood circulation. Purpose The current study was designed to verify the potential of aqueous methanolic crude extract of Asphodelus tenuifolius Cav . (At.Cr), used traditionally as remedy in circulatory problems. Research Design Antioxidant activity, FTIR, and HPLC analysis were performed. In-vitro clot lysis assay was performed on human blood samples, and in-vivo acute pulmonary thromboembolism model was developed by administering the mixture of collagen and epinephrine in tail vein of mice. Carrageenan-induced thrombosis and FeCl 3 -induced carotid arterial thrombosis models were developed in rats. Results At.Cr demonstrated significant increase in lysis of human blood clot. Bleeding and clotting times were increased dose-dependently. Lungs histology showed clear alveolar spaces with decreased red blood cells congestion. Reduction in infarcted tail length, augmentation in prothrombin time, and activated partial thromboplastin time with decrease in platelet count were observed. At.Cr also prolonged the arterial occlusion time and reduced the weight of thrombus and TXB 2 levels dose-dependently. Conclusions The results demonstrated the antithrombotic and thrombolytic potential of At.Cr due to activation of coagulation factors through extrinsic and intrinsic pathways.https://doi.org/10.1177/15593258221127566
spellingShingle Humaira Gul
Ayesha Jamshed
Qaiser Jabeen
Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
Dose-Response
title Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
title_full Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
title_fullStr Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
title_full_unstemmed Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
title_short Pharmacological Investigation of Cav for its Potential Against Thrombosis in Experimental Models
title_sort pharmacological investigation of cav for its potential against thrombosis in experimental models
url https://doi.org/10.1177/15593258221127566
work_keys_str_mv AT humairagul pharmacologicalinvestigationofcavforitspotentialagainstthrombosisinexperimentalmodels
AT ayeshajamshed pharmacologicalinvestigationofcavforitspotentialagainstthrombosisinexperimentalmodels
AT qaiserjabeen pharmacologicalinvestigationofcavforitspotentialagainstthrombosisinexperimentalmodels